Abstract:Oxidative stress including DNA damage, increased lipid and protein oxidation, are important features of aging and neurodegeneration suggesting that endogenous antioxidant protective pathways are inadequate or overwhelmed. Importantly, oxidative protein damage contributes to age-dependent accumulation of dysfunctional mitochondria or protein aggregates. In addition, environmental toxins such as rotenone and paraquat, which are risk factors for the pathogenesis of neurodegenerative diseases, also promote protein oxidation. The obvious approach of supplementing the primary antioxidant systems designed to suppress the initiation of oxidative stress has been tested in animal models and positive results were obtained. However, these findings have not been effectively translated to treating human patients, and clinical trials for antioxidant therapies using radical scavenging molecules such as α-tocopherol, ascorbate and coenzyme Q have met with limited success, highlighting several limitations to this approach. These could include: (1) radical scavenging antioxidants cannot reverse established damage to proteins and organelles; (2) radical scavenging antioxidants are oxidant specific, and can only be effective if the specific mechanism for neurodegeneration involves the reactive species to which they are targeted and (3) since reactive species play an important role in physiological signaling, suppression of endogenous oxidants maybe deleterious. Therefore, alternative approaches that can circumvent these limitations are needed. While not previously considered an antioxidant system we propose that the autophagy-lysosomal activities, may serve this essential function in neurodegenerative diseases by removing damaged or dysfunctional proteins and organelles.

Taming ROS: Mitochondria-Targeted AIEgen for Neuron Protection via Photosensitization-Triggered Autophagy

Taming Reactive Oxygen Species: Mitochondria-Targeting Aggregation-Induced Emission Luminogen for Neuron Protection via Photosensitization-Triggered Autophagy

Oxidative Stress Amplifiers As Immunogenic Cell Death Nanoinducers Disrupting Mitochondrial Redox Homeostasis for Cancer Immunotherapy.

Nanozymes targeting mitochondrial repair in disease treatment

A Mitochondria-Targeting ROS-activated Nanoprodrug for Self-Augmented Antitumor Oxidation Therapy

Mitochondria-Targeted Antioxidants: A Step towards Disease Treatment

Smart antioxidant function enhancing (SAFE) nucleic acid therapy for ROS-related chronic diseases and comorbidities

A Mitochondrial Oxidative Stress Amplifier to Overcome Hypoxia Resistance for Enhanced Photodynamic Therapy.

Molecular Regulation Mechanisms and Interactions Between Reactive Oxygen Species and Mitophagy.

Therapy of mitochondria-targeted hybrid nanozymes for reactive oxygen species-induced diseases

Mitochondria-targeted nanozymes eliminate oxidative damage in retinal neovascularization disease

A Reactive Oxygen Species‐Responsive Targeted Nanoscavenger to Promote Mitophagy for the Treatment of Alzheimer's Disease

An Aggregation-Induced Emission Photosensitizer with Efficient Singlet Oxygen Generation Capacity for Mitochondria Targeted Photodynamic Therapy

NRF2 Promotes Neuronal Survival in Neurodegeneration and Acute Nerve Damage.

Reactive Oxygen Species as a Link between Antioxidant Pathways and Autophagy

ROS production and mitochondrial dysfunction driven by PU.1-regulated NOX4-p22<SUP>phox</SUP> activation in A-induced retinal pigment epithelial cell injury

Reactive Oxygen Species-Induced Aggregation of Nanozymes for Neuron Injury

Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease

Single-Atom Nanocatalytic Therapy for Suppression of Neuroinflammation by Inducing Autophagy of Abnormal Mitochondria

Reactive Oxygen Species and Neurodegenerative Diseases: Insights into Nanozyme Therapeutics

Unraveling mitochondria‐targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials